首页> 外文期刊>Frontiers in Pharmacology >Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro
【24h】

Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro

机译:<斜体>石斛officinale 兰花提取物可防止卵巢切除术诱导的骨质疏松症<斜体>在体内并抑制RANKL诱导的骨质体分化<斜体>在体外

获取原文
       

摘要

Background: Dendrobium officinale , a traditional Chinese medical herb with high value that is widely used in Asia, possesses many positive effects on human health, including anti-chronic inflammation, anti-obesity, and immune modulation properties; however, whether D. officinale has inhibitory effects on postmenopausal osteoporosis remains unknown. Objective: We investigated the effects of D. officinale extract (DOE) on ovariectomy-induced bone loss in vivo and on osteoclastogenesis in vitro . Methods: In vivo , female rats were divided into a sham-operated (sham) group and five ovariectomized (OVX) subgroups: OVX with vehicle (OVX), OVX with Xian-Ling-Gu-Bao capsule (240 mg/kg body weight/day), and OVX with low-, medium-, and high-dose DOE (150, 300, and 600 mg/kg body weight/day, respectively). Animals in each group were administered their corresponding treatments for 13 weeks. Body weight, serum biochemical parameters, uterine and femoral physical parameters, bone mineral density (BMD), bone biomechanical properties, and bone microarchitecture were obtained. In vitro , the effects of DOE on osteoclastogenesis were examined using RAW264.7 cells. The effects of DOE on osteoclastogenesis and the expression of osteoclast-specific marker genes and proteins were determined. Results: DOE effectively ameliorated serum biochemical parameters, especially alleviated estradiol (E2) deficiency and maintained calcium and phosphorus homeostasis. DOE improved uterine and femoral physical parameters. In addition, DOE improved femoral BMD and biomechanical properties. DOE significantly ameliorated bone microarchitecture. Moreover, DOE inhibited osteoclastogenesis independent of its cytoxicity and suppressed the expression of osteoclast-specific marker genes and proteins. Conclusion: DOE can effectively prevent ovariectomy-induced bone loss in vivo and inhibit osteoclastogenesis in vitro .
机译:背景:石斛officinale,一种高价值的中国医学草本,广泛用于亚洲,对人类健康具有许多积极影响,包括抗慢性炎症,抗肥胖和免疫调节特性;但是,D. Officinale是否对绝经后骨质疏松症具有抑制作用仍然未知。目的:我们调查了D. Officinale提取物(DOE)对体内卵巢切除术诱导的骨质损失的影响和体外骨质细胞发生。方法:体内,雌性大鼠分为假手术(假)组和五种卵巢切除(OVX)亚组:含有载体(OVX)的OVX,具有Xian-Ling-Gu-Bao胶囊的OVX(240 mg / kg体重/天),以及低,中,高剂量DOE(150,300和600mg / kg体重/日)的OVX)。每组中的动物进行相应的治疗,13周。获得体重,血清生物化学参数,子宫和股骨物理参数,骨矿物密度(BMD),骨生物力学性能和骨微体系结构。在体外,使用Raw264.7细胞检查DOE对骨细胞发生发生的影响。测定了DOE对骨核细胞发生的影响和骨细胞特异性标记基因和蛋白质的表达。结果:DOE有效地改善了血清生物化学参数,特别是缓解雌二醇(E2)缺乏,维持钙和磷稳定性。 DOE改善子宫和股骨物理参数。此外,DOE改善了股骨BMD和生物力学性质。 DOE显着改善骨骼微体系程。此外,DOE抑制了骨髓细胞发生,与其细胞毒性无关,并抑制了骨细胞特异性标记基因和蛋白质的表达。结论:DOE可以有效地防止体内卵巢切除术引起的骨质损失,抑制体外骨质细胞发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号